Duffield is a third-year medical student at the Lewis Katz School of Medicine at Temple University in Philadelphia, Pennsylvania.
Bad Bugs, New Drugs: A Discussion of Selected New Therapeutics From IDWeek 2022
Cefepimetaniborbactam may represent a safe and effective
carbapenemsparing agent in cUTI and AP, whereas ridinilazole may play an important role in treating CDI.
2 Commerce Drive Cranbury, NJ 08512